Development of an ASRS-Based Photoguide for a Clinical Trial of TRTP-101 in Adults With Atrophic Scars

November 15, 2026 updated by: CellinCells

CIC101-02-PG aims to develop an ASRS-based photoguide for patients with atrophic acne scars.

Study Overview

Status

Not yet recruiting

Conditions

Study Type

Observational

Enrollment (Estimated)

52

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

      • Seoul, South Korea
        • Samsung Medical Center

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

19 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Individuals with Atrophic scars

Description

Inclusion Criteria:

  • Male or Female aged greater than 19 years
  • Participants with any grade according to the 5-point Acne Scar Rating Scale (ASRS)
  • Participants who voluntarily provide written informed consent to participate in this clinical trial

Exclusion Criteria:

  • Participants with an infectious condition or any dermatologic condition other than atrophic scars on the face
  • Participants with a any current serious acute, chronic, or progressive disease
  • Participants who are considered unsuitable for participation in the clinical trial for any other reason, as determined by the investigator

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: OTHER
  • Time Perspectives: PROSPECTIVE

Cohorts and Interventions

Group / Cohort
Cohort 1: ASRS grade 0

Participants classified as ASRS Grade 0

Cohort 2: ASRS grade 1

Participants classified as ASRS Grade 1

Cohort 3: ASRS grade 2

Participants classified as ASRS Grade 2

Cohort 4: ASRS grade 3

Participants classified as ASRS Grade 3

Cohort 5: ASRS grade 4

Participants classified as ASRS Grade 4

5 ASRS grade Cohorts

Participants are classified into five cohorts according to ASRS Grades 0-4.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Inter-rater Reliability of the Acne Scar Rating Scale (ASRS)
Time Frame: Within 4 weeks after completion of photograph collection

Inter-rater reliability of ASRS grading is assessed among three independent evaluators using standardised photographs of atrophic acne scars. Agreement among evaluators will be quantified using Fleiss' weighted kappa statistic.

Within 4 weeks after completion of photograph collection

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Intra-rater Reliability of the Acne Scar Rating Scale (ASRS)
Time Frame: Within 4 weeks after completion of photograph collection

Intra-rater reliability of ASRS grading is assessed for each of the three independent evaluators using 13 repeated photographs. Agreement between repeated assessments will be quantified using Cohen's weighted kappa statistic.

Within 4 weeks after completion of photograph collection

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

November 16, 2026

Primary Completion (Estimated)

February 26, 2027

Study Completion (Estimated)

May 30, 2027

Study Registration Dates

First Submitted

November 8, 2026

First Submitted That Met QC Criteria

November 15, 2026

First Posted (Actual)

November 18, 2026

Study Record Updates

Last Update Posted (Actual)

November 18, 2026

Last Update Submitted That Met QC Criteria

November 15, 2026

Last Verified

November 1, 2026

More Information

Terms related to this study

Other Study ID Numbers

  • CIC101-02-PG

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe